리타민(RETAMIN) - 건강한 투자 습관 vs 投資Talk君

리타민(RETAMIN) - 건강한 투자 습관 earns about $12.4K per month, while 投資Talk君 earns about $146. That is a 84.8× revenue gap (~$12.2K more per month for 리타민(RETAMIN) - 건강한 투자 습관). Annual revenue: 리타민(RETAMIN) - 건강한 투자 습관 ≈ $148.5K/year, 投資Talk君 ≈ $1.7K/year. Estimates are derived from public Google Play signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.

리타민(RETAMIN) - 건강한 투자 습관 leads with about 60K estimated downloads vs 3K for 投資Talk君 - a 23.4× gap. 리타민(RETAMIN) - 건강한 투자 습관 reports 50,000+ installs on Google Play. 投資Talk君 reports 1,000+ installs on Google Play.

Yes - both apps sit in the Finance category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.

리타민(RETAMIN) - 건강한 투자 습관: IAP range $7.29 - $61.99 per item. 投資Talk君: IAP range $39.99 - $599.99 per item. 리타민(RETAMIN) - 건강한 투자 습관 runs a "Subscription (~$21.26/mo)" monetization model; 投資Talk君 runs "Free + IAP (tiers not exposed by store)". Scraped tier prices and detected subscription pricing drive the bulk of the per-app revenue estimate above.

投資Talk君 edges ahead with a higher overall score (gap of 3.7 stars). Rating volume: 리타민(RETAMIN) - 건강한 투자 습관 0 ratings, 投資Talk君 2 ratings. Higher rating volume = stronger ASO signal even when star averages are close.

Directional - typically within 2-3× of actual money earned for popular apps. The $12.4K for 리타민(RETAMIN) - 건강한 투자 습관 and $146 for 投資Talk君 are derived from Google Play grossing rank, scraped IAP tiers, ratings volume and category benchmarks (Finance) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.

Use the search box at the bottom of this page or paste any two Google Play links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.